Document is current
Any future updates will be listed below
-
Authors
Bacchiocchi, Antonella
Mak, Michael
Khan, Zerin Mahzabin https://orcid.org/0000-0001-6033-2013
Gong, Xiangyu https://orcid.org/0000-0003-4033-9570
Sznol, Mario https://orcid.org/0000-0003-4137-9662
Na, Zhenkun
Su, Haomiao https://orcid.org/0000-0001-6232-6725
Chan, Lok Hei
Yan, Qin https://orcid.org/0000-0003-4077-453X
Zhao, Dejian
Mortlock, Ryland D. https://orcid.org/0000-0001-9666-4394
Knight, James
Slavoff, Sarah A. https://orcid.org/0000-0002-4443-2070
Halaban, Ruth https://orcid.org/0000-0001-8451-1964
-
Funding
Funding for this research was provided by:
Melanoma Research Alliance (None)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P50CA121974)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P50CA121974)
- License Information
-
More Information
Article History
Received: 29 December 2024
Revised: 24 June 2025
Accepted: 5 August 2025
First Online: 30 August 2025
Competing interests
: The authors declare no competing interests.
: We confirm that all methods were performed in accordance with the relevant guidelines and regulations. Research involving human participants was conducted in accordance with applicable laws, regulations, guidelines, and ethical principles such as those outlined in the Belmont Report. The research was approved by the Yale Human Research Protection Program (HRPP), registration number FWA00002571, which includes the Institutional Review Board (IRB), responsible for ensuring compliance with these standards and Yale’s institutional policies. Its goal is to: Ensure the rights and welfare of human research participants; Promote excellence in the conduct of research; and Advance scientific knowledge and quality research (). Informed consent was obtained from all the participants with IRB Protocol ID: 060900186. Title of Study: Yale Specimen and Data Repository. Investigator: Ruth Halaban.
